The Rare Disease Research Consortim (IRDiRC) recognizes that rare disease therapeutics and orphan drug development represent unique scientific challenges. We are thrilled to share that Certara’s Senior Director of Regulatory Strategy, Oxana Iliach, PhD. has been elected a member of the newly created Regulatory Science Committee at IRDiRC to help tackle regulatory challenges in rare disease research.
IRDiRC Announces Creation of Regulatory Scientific Committee to Tackle Regulatory Challenges in Rare Diseases Research – Press Release
2022年9月23日